SCHEMBL5864015

SCHEMBL5864015

Cc1cc(C)c(S(=O)(=O)N(Cc2cccc(O)c2)c2ccc(/C=C/C(=O)NCCc3ccncc3)cc2)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.47
MMP2 P08253 4/20 0.47
MMP9 P14780 4/20 0.47
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.41
RECQL P46063 1/20 0.41
LMNA P02545 1/20 0.41
ARG1 P05089 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX5 P09917 1/20 0.41
CNR2 P34972 1/20 0.40
MAPT P10636 1/20 0.40
NLRP3 Q96P20 1/20 0.40
PKM P14618 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
PTGER1 P34995 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864018 1.00 MMP1 (0.47) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL5864491 0.84 ALDH1A1 (0.57) KDM4ELMNAMEN1KMT2AMAPT
SCHEMBL5864494 0.84 ALDH1A1 (0.57) KDM4ELMNAMEN1KMT2AMAPT
SCHEMBL5863823 0.82 CNR2 (0.36) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL5863737 0.82 AKR1C3 (0.41) LMNAMAPT
SCHEMBL5863735 0.82 AKR1C3 (0.41) LMNAMAPT
SCHEMBL5863717 0.82 MMP1 (0.47) MMP1MMP2MMP9POLBLMNA
SCHEMBL5863722 0.82 MMP1 (0.47) MMP1MMP2MMP9POLBLMNA
SCHEMBL5864248 0.82 ALDH1A1 (0.47) KDM4ELMNAKMT2A
SCHEMBL5864243 0.82 ALDH1A1 (0.47) KDM4ELMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
EP-1542967-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR Pfizer Products Inc. (US) 2005-06-22 EP disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed
WO-2004026823-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR PFIZER PRODUCTS INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 MMP1 1746/4885MMP2 1702/4885MMP9 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.